0001237899-12-000030.txt : 20120223 0001237899-12-000030.hdr.sgml : 20120223 20120223114615 ACCESSION NUMBER: 0001237899-12-000030 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120221 FILED AS OF DATE: 20120223 DATE AS OF CHANGE: 20120223 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Powchik Peter CENTRAL INDEX KEY: 0001377247 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 12632683 MAIL ADDRESS: STREET 1: REGENERON PHARMACEUTICALS, INC. STREET 2: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 4 1 edgardoc.xml PRIMARY DOCUMENT X0304 4 2012-02-21 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001377247 Powchik Peter 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 SVP Clinical Development & Reg Common Stock 2012-02-21 4 M 0 49428 15.64 A 64572 D Common Stock 2012-02-21 4 F 0 7705 100.32 D 56867 D Common Stock 2012-02-21 4 F 0 18530 100.32 D 38337 D Common Stock 2012-02-21 4 M 0 20000 20.32 A 58337 D Common Stock 2012-02-21 4 F 0 4050 100.32 D 54287 D Common Stock 2012-02-21 4 F 0 7347 100.32 D 46940 D Common Stock 2012-02-21 4 M 0 25438 21.92 A 72378 D Common Stock 2012-02-21 4 F 0 5558 100.32 D 66820 D Common Stock 2012-02-21 4 F 0 9158 100.32 D 57662 D Common Stock 2012-02-21 4 M 0 15000 16.8 A 72662 D Common Stock 2012-02-21 4 F 0 2511 100.32 D 70151 D Common Stock 2012-02-21 4 F 0 5753 100.32 D 64398 D Common Stock 2012-02-22 4 S 0 4200 94.71 D 60198 D Common Stock 2012-02-22 4 S 0 10800 95.46 D 49398 D Common Stock 2012-02-22 4 S 0 23454 96.45 D 25944 D Common Stock 2012-02-22 4 S 0 9600 97.58 D 16344 D Common Stock 2012-02-22 4 S 0 1200 98.05 D 15144 D Common Stock 1532 I By 401(k) Plan Non-Qualified Stock Option (right to buy) 15.64 2012-02-21 4 M 0 49428 D 2016-10-02 Common Stock 49428 0 D Non-Qualified Stock Option (right to buy) 16.8 2012-02-21 4 M 0 15000 D 2018-12-17 Common Stock 15000 30000 D Non-Qualified Stock Option (right to buy) 20.32 2012-02-21 4 M 0 20000 D 2016-12-18 Common Stock 20000 0 D Non-Qualified Stock Option (right to buy) 21.92 2012-02-21 4 M 0 25438 D 2017-12-17 Common Stock 25438 0 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 4,200 shares of Company stock on February 22, 2012 at prices ranging from $94.22 to $94.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 22, 2012 at each separate price. Represents volume-weighted average price of sales of 10,800 shares of Company stock on February 22, 2012 at prices ranging from $95.00 to $95.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 22, 2012 at each separate price. Represents volume-weighted average price of sales of 23,454 shares of Company stock on February 22, 2012 at prices ranging from $96.00 to $96.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 22, 2012 at each separate price. Represents volume-weighted average price of sales of 9,600 shares of Company stock on February 22, 2012 at prices ranging from $97.00 to $97.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 22, 2012 at each separate price. Represents volume-weighted average price of sales of 1,200 shares of Company stock on February 22, 2012 at prices ranging from $98.01 to $98.27. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 22, 2012 at each separate price. The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant. Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case. The stock option award vests in four equal annual installments, commencing one year after the date of grant. /s/**Peter Powchik 2012-02-23